Clinical Trials on Contiguous Stage II Mantle Cell Lymphoma
Total 1504 results
-
CelgeneTerminatedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States, Spain, United Kingdom, Germany, France, Czechia, Israel, Italy, Poland, Portugal, Puerto Rico, Russian Federation
-
PfizerCompletedNon-Hodgkin's LymphomaKorea, Republic of, Australia, Czechia, United States, Romania, Germany, France, Poland, Italy, Russian Federation, Serbia
-
Weill Medical College of Cornell UniversityCompleted
-
Charite University, Berlin, GermanyWyeth is now a wholly owned subsidiary of Pfizer; Mundipharma K.K.WithdrawnMantle Cell LymphomaGermany
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingMantle Cell LymphomaUnited States
-
Dalian Medical UniversityNot yet recruiting
-
Shanxi Province Cancer HospitalNot yet recruiting
-
C. Babis AndreadisEli Lilly and Company; Genentech, Inc.; Adaptive BiotechnologiesRecruitingMantle Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
Fondazione Italiana Linfomi - ETSRecruiting
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingMantle Cell LymphomaUnited States, France, Poland, United Kingdom, China, Belgium, Germany, Taiwan, Spain, Argentina, Israel, Turkey, Ukraine, Japan, Canada, Greece, Korea, Republic of, Netherlands, Brazil, Russian Federation, Puerto Rico, Australia, I... and more
-
Acerta Pharma BVAstraZenecaActive, not recruitingLymphoma, Mantle CellUnited States, France, Italy, Taiwan, Mexico, Russian Federation, Vietnam, Belgium, Canada, Brazil, Hungary, Japan, Poland, China, Spain, Germany, Australia, Czechia, Korea, Republic of, Israel, Romania, Ukraine, Argentina, Peru, New Zealand and more
-
Fondazione Italiana Linfomi - ETSActive, not recruiting
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Germany, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
SCRI Development Innovations, LLCAcerta Pharma, LLCCompletedMantle Cell LymphomaUnited States
-
The Lymphoma Academic Research OrganisationActive, not recruiting
-
The Lymphoma Academic Research OrganisationActive, not recruitingMantle Cell LymphomaFrance, Spain, Belgium, Netherlands, Germany, Poland, Portugal
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
Eli Lilly and CompanyCompleted
-
Guangzhou Lupeng Pharmaceutical Company LTD.Completed
-
Weill Medical College of Cornell UniversityCelgeneCompleted
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.CompletedMantle Cell LymphomaCanada
-
Zhejiang DTRM BiopharmaCompleted
-
Fondazione Italiana Linfomi ONLUSActive, not recruiting
-
Fondazione Italiana Linfomi ONLUSCompleted
-
Samsung Medical CenterUnknownMantle Cell LymphomaKorea, Republic of
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
University of Wisconsin, MadisonCompleted
-
GlaxoSmithKlineCompleted
-
Weill Medical College of Cornell UniversityPfizer; Millennium Pharmaceuticals, Inc.TerminatedMantle Cell LymphomaUnited States
-
Lymphoma Study AssociationTerminated
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaFrance, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Colombia, Portugal, Ukraine, Canada, Netherlands, Sweden, Korea, Republic of, Chile, Brazil, Russian Federation, Hungary, Ireland, Mexico, Czechia
-
Prof. Dr. M. Dreyling (co-chairman)ClinAssess GmbH; Klinikum der Universitaet Muenchen, Grosshadern; GELARC Service...UnknownMantle Cell LymphomaFrance, Germany
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaUnited States, France, United Kingdom, Belgium, Spain, Israel, Puerto Rico, Poland, Russian Federation
-
French Innovative Leukemia OrganisationMundipharma Pte Ltd.; Janssen, LPCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; BiogenCompletedMantle Cell LymphomaUnited States
-
Institute of Cancer Research, United KingdomAustralasian Leukaemia and Lymphoma GroupCompletedLymphomaAustralia, United Kingdom
-
German Low Grade Lymphoma Study GroupEuropean Organisation for Research and Treatment of Cancer - EORTC; Lymphoma... and other collaboratorsUnknown
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
St. Bortolo HospitalCompletedLymphoma, Mantle-CellItaly
-
Southern Europe New Drug OrganizationFondazione IRCCS Istituto Nazionale dei Tumori, MilanoUnknownLymphoma, Mantle-CellItaly
-
French Innovative Leukemia OrganisationHoffmann-La RocheCompletedMantle Cell LymphomaFrance
-
Marcela V. Maus, M.D.,Ph.D.RecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Non-hodgkin Lymphoma | High-grade B-cell Lymphoma | Grade 3b Follicular Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
University of WashingtonBristol-Myers SquibbActive, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma and other conditionsUnited States
-
Cellectar Biosciences, Inc.RecruitingMultiple Myeloma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Central Nervous System LymphomaUnited States, Australia, Czechia, Greece, Israel, Brazil, Finland, France, Spain, Turkey, United Kingdom
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingB-cell Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Korea, Republic of, Australia, Japan, United Kingdom, Italy, Poland, France, Switzerland, Sweden
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell LymphomaUnited States